Albert Teis
Overview
Explore the profile of Albert Teis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Casas G, Rodenas-Alesina E, Limeres J, Badia-Molins C, Larranaga-Moreira J, Mirelis J, et al.
Rev Esp Cardiol (Engl Ed)
. 2025 Feb;
PMID: 39920987
Introduction And Objectives: Defining the probability of cardiomyopathy in individuals with excessive trabeculation of the left ventricle (ETLV) is an unmet clinical need. Our aims were: a) to describe the...
2.
De Raffele M, Teis A, Cediel G, Weerts J, Conte C, Junca G, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Jan;
PMID: 39874262
Aims: How the underlying etiology and pathophysiology of left ventricular (LV) hypertrophy affects LA remodeling and function remains unexplored. The present study aims to investigate the influence of various hypertrophic...
3.
Kasa G, Teis A, De Raffele M, Cediel G, Junca G, Lupon J, et al.
Eur Heart J Cardiovasc Imaging
. 2025 Jan;
PMID: 39792882
Aims: To investigate the distribution of left atrioventricular coupling index (LACI) among patients with heart failure and left ventricular ejection fraction (LVEF)<50% and to explore its association with the combined...
4.
Left Atrial Structure and Function Following Ethanol Infusion into Vein of Marshall (MR-SHALL Study)
Aranyo J, Junca G, Sarrias A, Bazan V, Cea D, Villuendas R, et al.
J Cardiovasc Electrophysiol
. 2024 Nov;
36(1):157-167.
PMID: 39513487
Background: Ethanol infusion into the vein of Marshall (EI-VOM) is an adjunctive therapy to pulmonary vein isolation (PVI), which improves the efficacy of persistent atrial fibrillation (AF) ablation procedures. It...
5.
Martinez-Falguera D, Aranyo J, Teis A, Ferrer-Curriu G, Monguio-Tortajada M, Fadeuilhe E, et al.
Circ Arrhythm Electrophysiol
. 2024 Apr;
17(5):e012517.
PMID: 38666379
Background: Sacubitril/valsartan (Sac/Val) is superior to angiotensin-converting enzyme inhibitors in reducing the risk of heart failure hospitalization and cardiovascular death, but its mechanistic data on myocardial scar after myocardial infarction...
6.
Bayes-Genis A, Gastelurrutia P, Monguio-Tortajada M, Camara M, Prat-Vidal C, Cediel G, et al.
EBioMedicine
. 2024 Mar;
102:105060.
PMID: 38490102
Background: In preclinical studies, the use of double allogeneic grafts has shown promising results in promoting tissue revascularization, reducing infarct size, preventing adverse remodelling and fibrosis, and ultimately enhancing cardiac...
7.
Kasa G, Teis A, Junca G, Aimo A, Lupon J, Cediel G, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Jan;
25(6):849-856.
PMID: 38246859
Aims: To assess the agreement between left ventricular end-diastolic diameter index (LVEDDi) and volume index (LVEDVi) to define LV dilatation and to investigate the respective prognostic implications in patients with...
8.
Ferrer-Sistach E, Teis A, Escabia C, Delgado V
Curr Cardiol Rep
. 2023 Dec;
26(1):1-14.
PMID: 38091195
Purpose Of The Review: The role of multimodality imaging in the evaluation of patients with aortic regurgitation is summarized in this review. Recent Findings: The etiology (mechanism) of the aortic...
9.
Junca G, Teis A, Kasa G, Ferrer-Sistach E, Vallejo N, Lopez-Ayerbe J, et al.
Rev Esp Cardiol (Engl Ed)
. 2023 Dec;
77(7):515-523.
PMID: 38061424
Introduction And Objectives: The present study sought to establish the diagnostic yield of cardiovascular magnetic resonance (CMR) in a large cohort of patients admitted with myocardial infarction (MI) with nonobstructive...
10.
Mateu L, Tebe C, Loste C, Santos J, Llados G, Lopez C, et al.
Lancet Reg Health Eur
. 2023 Nov;
33:100724.
PMID: 37954002
Background: At least 5-10% of subjects surviving COVID-19 develop the post-COVID-19 condition (PCC) or "Long COVID". The clinical presentation of PCC is heterogeneous, its pathogenesis is being deciphered, and objective,...